戻る Agenda
Risk Minimization Program Evaluation: How Can we Advance the Science?
Session Chair(s)
Meredith Yearsley Smith, PhD, MPA, FISPE
Fellow and faculty member
USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, United States
This forum will explore the use of different evaluation designs and measurement approaches to advance the science of risk minimization program evaluation and include a recent case study to illustrate points.
Learning Objective : Define methodologic features of high-impact risk minimization program evaluation designs; Review existing risk evaluation and mitigation strategies (REMS) case studies and opportunities to improve their evaluation, including consideration of contextual factors and assessment of potential burden on the healthcare system; Describe how to improve the likelihood of publication of evaluation studies.
Speaker(s)
Panelist
Almut G Winterstein, PhD, RPh, FISPE
University of Florida, United States
Distinguished Professor
Panelist
Giampiero Mazzaglia, MD, PhD, MSc
University of Milan, Italy
Associate Professor of Hygiene and Public Health
Panelist
Rachael L. DiSantostefano, PhD, MS
Janssen Research & Development, LLC, United States
Senior Director, Epidemiology
Panelist
Vincent Lo Re, MD, MS, FISPE
Pharmacoepidemiology and Drug Safety, United States
Associate Professor, U of Penn; Regional Editor of Americas, PDS
Panelist
Gianluca Trifiro, MD, PhD
University of Verona, Italy
Scientific Lead, INSPIRE; Professor, Pharmacology, Diagnostics and Public Health